Chemotherapy-induced Alopecia Clinical Trial
Official title:
"Impacto de la Alopecia Inducida Por Quimioterapia en la Calidad de Vida de Mujeres Con cáncer de Mama"
The main objective of this qualitative phenomenological study is to understand the impact of
chemotherapy-induced alopecia, the quality of life of women with breast cancer from this
experience.
The study will be conducted in the day hospital oncology-hematology of the Hospital de la
Santa Creu i Sant Pau. Data collection will be done through semi-structured interviews.
About 12 to 14 interviews throughout the study was conducted. So in the study involved a
total of between 12 and 14 women.
These will be recorded in voice and then transcribe and code. From reading and re-reading
the patterns or data that relate to each other, thus establishing the categories (thematic
analysis) were identified. These categories describe the experiences of the participants
alopecia.
The main objective of this study is to understand the impact of chemotherapy-induced
alopecia, the quality of life of women with breast cancer from this experience.
Therefore, it is a qualitative phenomenological study. The problem of the study is the
impact of alopecia as a side effect of chemotherapy in women with breast cancer in the areas
of privacy, welfare, sexuality and femininity, self-esteem, social relations and the world
of work.
The study will be conducted in the day hospital oncology-hematology of the Hospital de la
Santa Creu i Sant Pau. Data collection will be done through semi-structured interviews. Each
interview will last between 60 and 90 minutes will be the participant who decides the date
and time. The site will be a day hospital office.
It will be the same researcher who interviewed and analyze them. To make the selection of
participants with an opinion sampling is performed. Attracting participants who are patients
in the study investigator.
Inclusion criteria are: being female, of age, suffer from breast cancer, receive or have
received chemotherapy have the side effect of alopecia and alopecia file or have filed at
the time of the interview. Excluded from the study participants to present cognitive
impairment, intellectual disability, presence of disease that prevents the story of their
experience and / or not be able to sign the study informed orally and written consent.
About 12 to 14 interviews throughout the study was conducted. So in the study involved a
total of between 12 and 14 women.
These will be recorded in voice and then transcribe and code. From reading and re-reading
the patterns or data that relate to each other, thus establishing the categories (thematic
analysis) were identified. These categories describe the experiences of the participants
alopecia.
In a first phase of the project only 6 interviews will be conducted, as it requires the
presentation of preliminary results as part of a master work carried out by the principal
investigator. Subsequently, the remaining interviews will be conducted and the results will
be analyzed in its entirety.
These six interviews are conducted between June and July 2016 total planned month duration
of the study: 8 months.
Ethical considerations of this study are that to participate in the study informed consent
is required describing procedures and the role of the participants, stressing the voluntary
and total freedom to leave when they want. where the information sheet explaining why the
study, its purpose and the importance of their participation among others shall also be
included.
In addition, interviews will be recorded only voice and difficult to identify the
participants. Finally, compliance with current regulations concerning the confidentiality
and anonymity of the data is guaranteed.
This study does not have sources of funding.
;
Observational Model: Case-Only, Time Perspective: Cross-Sectional
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04986579 -
Scalp Cooling in MBC
|
Phase 2 | |
| Recruiting |
NCT06215469 -
Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads)
|
N/A | |
| Not yet recruiting |
NCT05484973 -
Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss
|
N/A | |
| Recruiting |
NCT06020586 -
Study To Evaluate The Efficacy And Safety Profile of ECOHAIR in Chemo-induced Alopecia.
|
N/A | |
| Recruiting |
NCT04036994 -
PBMT for the Management of CIA ( HAIRLASER )
|
N/A | |
| Completed |
NCT03712696 -
Efficacy and Safety of DIGNICAP™ System
|
N/A | |
| Recruiting |
NCT05177289 -
Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Alopecia
|
N/A | |
| Recruiting |
NCT06011525 -
Prevention of Alopecia in Patients With Localised Breast Cancer
|
N/A | |
| Recruiting |
NCT05397457 -
Effect of Helmet Type, Home-use Low-level Light Therapy Device for Chemotherapy-induced Alopecia
|
N/A | |
| Withdrawn |
NCT05365243 -
A Pilot Study to Evaluate the Use of the AMMA Portable Scalp Cooling System From Cooler Heads
|
N/A |